Rod James
Rod James is a reporter with Secondaries Investor and also contributes to sister title PrivateEquityInternational.com. He is based in the London office. Prior to PEI, his roles included a stint as a freelancer covering fintech and transaction banking, CEEMEA capital markets reporter with EMEA Finance magazine, and editor of the Latin American political and economic risk team at IHS Global Insight.
Park Hill is understood to be running the process which involves omega-3 producer KD Pharma Bexbach.
A stake in the Dutch PE firm's 2015-vintage fund sold for 121% of NAV, according to a survey of recent transactions by the online marketplace, with average pricing at par.
Tom Hodge, who was previously a senior associate, will lead the firm's in-house legal and compliance function.
At least $36bn worth of fund stakes changed hands in the first half of the year with GP-led deals accounting for 34% of the total, according to the intermediary.
Partner Martha Heitmann discusses ESG-driven secondaries sales and what to do if a portfolio sets off alarms.
Thomas Carbonel will be responsible for transaction execution at the niche secondaries firm, which is investing its $365m third fund.
Matthew Sparks, who ranked 13th in last year's Young Guns ranking, has been with the mid-market secondaries firm for more than nine years.
The Asian directs specialist has raised nearly 90% of the capital it's seeking for NewQuest Asia Fund IV, which has been in market since at least April.
Jeff Akers and Pinal Nicum of Adams Street Partners discuss their latest fundraise, the rise of SMAs and the limitations of relying on leverage to generate returns.
The deal involves stakes in 10 emerging-market assets from MTN Group, Africa's largest telecoms company.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: